Taysha Gene Therapies Inc. (TSHA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Taysha Gene Therapies Inc...

NASDAQ: TSHA · Real-Time Price · USD
4.76
-0.12 (-2.46%)
At close: Oct 03, 2025, 3:59 PM
4.76
0.00%
After-hours: Oct 03, 2025, 07:55 PM EDT

Taysha Gene Therapies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
139.04M 143.94M 87.88M 149.1M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
2.15M 2.15M 2.64M 2.64M
Other Long-Term Assets
217K 304K 3.95M 1.11M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
892K 4.83M 6.03M 6.63M
Total Current Assets
142.13M 149.87M 96.42M 159.6M
Property-Plant & Equipment
15.87M 20.41M 25.91M 50.61M
Goodwill & Intangibles
n/a n/a -4.99M n/a
Total Long-Term Assets
18.23M 22.86M 29.86M 54.35M
Total Assets
160.36M 172.73M 126.28M 213.96M
Account Payables
3.59M 6.37M 10.95M 21.76M
Deferred Revenue
9.77M 18.11M 33.56M n/a
Short-Term Debt
2.27M 1.65M 1.52M n/a
Other Current Liabilities
4.16M 5.57M 12.73M 4.13M
Total Current Liabilities
26.23M 36.76M 62.79M 51.75M
Long-Term Debt
43.94M 40.51M 37.97M 37.19M
Other Long-Term Liabilities
930K 1.58M 4.13M 3.73M
Total Long-Term Liabilities
62.61M 61.04M 62.54M 66.83M
Total Liabilities
88.84M 97.79M 125.33M 118.57M
Total Debt
63.18M 61.11M 59.93M 63.09M
Book Value
71.53M 74.94M 949K 95.38M
Book Value Per Share
0.29 0.32 0.01 0.63
Common Stock
2K 2K 1K n/a
Retained Earnings
-602.3M -513.01M -401.44M -235.65M
Comprehensive Income
-4.03M n/a n/a n/a
Shareholders Equity
71.53M 74.94M 949K 95.38M
Total Investments
2.15M 2.15M 2.64M 2.64M